Mick Arber

WHICH DATABASES SHOULD BE USED TO IDENTIFY STUDIES FOR SYSTEMATIC REVIEWS OF ECONOMIC EVALUATIONS?

Mick Arber, Julie Glanville, Jaana Isojärvi et al. · International Journal of Technology Assessment in Health Care · 2018 · 31 citations · Full text

Social Sciences, Pharmacoeconomics, Cost-effectiveness Analysis +15

PERFORMANCE OF OVID MEDLINE SEARCH FILTERS TO IDENTIFY HEALTH STATE UTILITY STUDIES

Mick Arber, Sonia Garcia Gonzalez-Moral, Thomas Veale et al. · International Journal of Technology Assessment in Health Care · 2017 · 29 citations

Pharmacy, Biomedical Informatics, Clinical Decision Support +11

Comparative assessment of onabotulinumtoxinA and mirabegron for overactive bladder: an indirect treatment comparison

Nick Freemantle, David A. Ginsberg, Rachael McCool et al. · BMJ Open · 2016 · 18 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Inventory of Sources of Scientific Evidence Relevant to EFSA's Risk Assessments and Information Sessions on Literature Searching Techniques (CFT/EFSA/SAS/2011/03 Inventory Report)

Julie Glanville, Danielle Varley, Hugh Brazier et al. · EFSA Supporting Publications · 2014 · 10 citations · Full text

Pharmacy, Risk Management, Risk Analysis +13